TIMM44 and ovarian serous adenocarcinoma: Furthermore, an intragenic CpG island in TIMM44 has been found to be hypomethylated in aggressive serous ovarian cancers [42], and its expression is positively associated with recurrence after chemotherapy in breast cancer patients [43].